跳至主要内容
临床试验/TCTR20170525001
TCTR20170525001已完成未知

Islets beta-cell function and usefulness of sulfonylureas in glycemic control in type 2 diabetic patients with sulfonylurea failure.

one0 个研究点目标入组 25 人开始时间: 2017年5月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
one
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 0 N/A (No limit)(—)
性别
All

入选标准

  • Type 2 diabetic patients who had sulfonylurea failure. Sulfonylurea failure defined by the presence of hemoglobin A1C levels of >8% for longer than 6 months during treatment with combination of recommended maximum dosages of an SU and metformin.

排除标准

  • Currently treated with insulin and dipeptidyl peptidase-4 (DPP-4) inhibitors, glucocorticoid therapy, acute illnesses and infections, serum creatinine levels of >1.5 mg/dL, and serum aspartate transferase (AST) and/or alanine transferase (ALT) levels of >3 times higher than the upper limit of normal ranges, and history of diabetic ketoacidosis or hyperglycemic hyperosmolar non-ketotic state.

研究者

发起方
one

相似试验